Table of contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Healthcare Spending on mRNA Technology, by Region (2023)
5.2 Regulatory Approvals and Tresnds (2023)
5.3 Clinical Trial Trends for mRNA Technology (2023)
5.4 Investment and Funding in mRNA Technology (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. mRNA Technology Market Segmentation, by Technology Platform
7.1 Chapter Overview
7.2 mRNA Vaccines
7.2.1 mRNA Vaccines Market Trends Analysis (2020-2032)
7.2.2 mRNA Vaccines Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Therapeutic mRNA
7.3.1 Therapeutic mRNA Market Trends Analysis (2020-2032)
7.3.2 Therapeutic mRNA Market Size Estimates and Forecasts to 2032 (USD Billion)
8. mRNA Technology Market Segmentation, By Delivery Method
8.1 Chapter Overview
8.2 Lipid Nanoparticles (LNPs)
8.2.1 Lipid Nanoparticles (LNPs) Market Trends Analysis (2020-2032)
8.2.2 Lipid Nanoparticles (LNPs) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Polymeric Carriers
8.3.1 Polymeric Carriers Market Trends Analysis (2020-2032)
8.3.2 Polymeric Carriers Market Size Estimates And Forecasts To 2032 (USD Billion)
8.4 Electroporation
8.4.1 Electroporation Market Trends Analysis (2020-2032)
8.4.2 Electroporation Market Size Estimates And Forecasts To 2032 (USD Billion)
9. mRNA Technology Market Segmentation, by Application
9.1 Chapter Overview
9.2 Infectious Diseases
9.2.1 Infectious Diseases Market Trends Analysis (2020-2032)
9.2.2 Infectious Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Cancer Immunotherapy
9.3.1 Cancer Immunotherapy Market Trends Analysis (2020-2032)
9.3.2 Cancer Immunotherapy Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Genetic Disorders
9.4.1 Genetic Disorders Market Trends Analysis (2020-2032)
9.4.2 Genetic Disorders Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Cardiovascular Diseases
9.5.1 Cardiovascular Diseases Market Trends Analysis (2020-2032)
9.5.2 Cardiovascular Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
10. mRNA Technology Market Segmentation, By End User
10.1 Chapter Overview
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Pharmaceutical & Biotechnology Companies Market Trends Analysis (2020-2032)
10.2.2 Pharmaceutical & Biotechnology Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Research Institutes
10.3.1 Research Institutes Market Trends Analysis (2020-2032)
10.3.2 Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Hospitals & Clinics
10.4.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
10.4.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.2.4 North America mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.2.5 North America mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.6 North America mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.2.7.2 USA mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.2.7.3 USA mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.7.4 USA mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.2.8.2 Canada mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.2.8.3 Canada mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.8.4 Canada mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.2.9.2 Mexico mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.2.9.3 Mexico mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.9.4 Mexico mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.7.2 Poland mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.7.3 Poland mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.7.4 Poland mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.8.2 Romania mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.8.3 Romania mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.8.4 Romania mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.9.2 Hungary mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.9.3 Hungary mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.9.4 Hungary mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.10.2 Turkey mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.10.3 Turkey mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.10.4 Turkey mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.4 Western Europe mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.5 Western Europe mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.6 Western Europe mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.7.2 Germany mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.7.3 Germany mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.7.4 Germany mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.8.2 France mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.8.3 France mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.8.4 France mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.9.2 UK mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.9.3 UK mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.9.4 UK mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.10.2 Italy mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.10.3 Italy mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.10.4 Italy mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.11.2 Spain mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.11.3 Spain mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.11.4 Spain mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.14.2 Austria mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.14.3 Austria mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.14.4 Austria mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.4 Asia Pacific mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.5 Asia Pacific mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.6 Asia Pacific mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.7.2 China mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.7.3 China mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.7.4 China mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.8.2 India mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.8.3 India mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.8.4 India mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.9.2 Japan mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.9.3 Japan mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.9.4 Japan mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.10.2 South Korea mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.10.3 South Korea mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.10.4 South Korea mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.11.2 Vietnam mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.11.3 Vietnam mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.11.4 Vietnam mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.12.2 Singapore mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.12.3 Singapore mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.12.4 Singapore mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.13.2 Australia mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.13.3 Australia mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.13.4 Australia mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.4 Middle East mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.5 Middle East mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.6 Middle East mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.7.2 UAE mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.7.3 UAE mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.7.4 UAE mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.8.2 Egypt mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.8.3 Egypt mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.8.4 Egypt mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.10.2 Qatar mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.10.3 Qatar mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.10.4 Qatar mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.2.4 Africa mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.2.5 Africa mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.6 Africa mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.2.7.2 South Africa mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.2.7.3 South Africa mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.7.4 South Africa mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America mRNA Technology Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.6.4 Latin America mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.6.5 Latin America mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.6 Latin America mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.6.7.2 Brazil mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.6.7.3 Brazil mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.7.4 Brazil mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.6.8.2 Argentina mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.6.8.3 Argentina mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.8.4 Argentina mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.6.9.2 Colombia mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.6.9.3 Colombia mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.9.4 Colombia mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America mRNA Technology Market Estimates and Forecasts, by Technology Platform (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America mRNA Technology Market Estimates and Forecasts, By Delivery Method (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America mRNA Technology Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America mRNA Technology Market Estimates and Forecasts, By End User (2020-2032) (USD Billion)
12. Company Profiles
12.1 Moderna, Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product / Services Offered
12.1.4 SWOT Analysis
12.2 Pfizer-BioNTech
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Product / Services Offered
12.2.4 SWOT Analysis
12.3 CureVac N.V.
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Product / Services Offered
12.3.4 SWOT Analysis
12.4 Arcturus Therapeutics
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Product / Services Offered
12.4.4 SWOT Analysis
12.5 Sanofi
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Product / Services Offered
12.5.4 SWOT Analysis
12.6 Genentech (Roche)
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Product / Services Offered
12.6.4 SWOT Analysis
12.7 Vaxart
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Product / Services Offered
12.7.4 SWOT Analysis
12.8 eTheRNA immunotherapies
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Product / Services Offered
12.8.4 SWOT Analysis
12.9 GSK (GlaxoSmithKline)
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Product / Services Offered
12.9.4 SWOT Analysis
12.10 Helmholtz Center for Infection Research (HZI)
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Product / Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
